{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:10:19Z","timestamp":1780625419740,"version":"3.54.1"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019533","name":"Moderna","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019533","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Cell-mediated immunity may provide durable protection against severe COVID-19, including among solid organ transplant recipients (SOTRs). This exploratory analysis in the open-label phase 3b trial evaluated cell-mediated immunity of mRNA-1273 in a subset of participants (59 kidney and 33 liver SOTRs; 12 immunocompetent participants).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In Part A, SOTRs received three 100-\u00b5g doses of mRNA-1273; immunocompetent participants received two doses. In Part B, an additional 100-\u00b5g dose was offered \u22654 months after the primary series. SARS-CoV-2 spike (S) protein-specific T-cell responses were measured by intracellular cytokine staining and polyfunctionality analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The primary series and additional dose of mRNA-1273 induced S protein-specific CD4<jats:sup>+<\/jats:sup> T-cell responses exhibiting a Th-1-biased profile in both SOTRs and immunocompetent participants; however, response rates and magnitudes were lower among SOTRs. S protein-specific Th-2 CD4<jats:sup>+<\/jats:sup> T-cell responses were below those observed for Th-1; CD8<jats:sup>+<\/jats:sup> T-cell responses were not as robust among SOTRs compared with immunocompetent participants. Kidney SOTRs received multiple immunosuppressants and had lower cell-mediated immunity responses than liver SOTRs. Polyfunctional responses exhibited Th-1 cytokine signatures with \u22645 functional markers reported in SOTRs and immunocompetent participants.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Overall, a three-dose mRNA-1273 primary series elicited Th-1-biased CD4<jats:sup>+<\/jats:sup> T-cell responses among SOTRs that were improved with an additional dose.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical trial registration<\/jats:title><jats:p><jats:uri>https:\/\/beta.clinicaltrials.gov\/study\/NCT04860297?term=NCT04860297%20&amp;amp;rank=1<\/jats:uri>, identifier NCT04860297.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1505871","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T01:09:53Z","timestamp":1743728993000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["mRNA-1273 COVID-19 vaccine induces CD4+ T-cell responses among solid organ transplant recipients"],"prefix":"10.3389","volume":"16","author":[{"given":"Bethany","family":"Girard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amparo L.","family":"Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Juliana","family":"McElrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamil R.","family":"Azzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Stolman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma","family":"Siangphoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"de Windt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline M.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rituparna","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Priddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5162","DOI":"10.3390\/jcm10215162","article-title":"Incidence of mortality, acute kidney injury and graft loss in adult kidney transplant recipients with coronavirus disease 2019: systematic review and meta-analysis","volume":"10","author":"Chen","year":"2021","journal-title":"J Clin Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2021.7024","article-title":"Association between immune dysfunction and COVID-19 breakthrough infection after SARS-CoV-2 vaccination in the US","volume":"182","author":"Sun","year":"2022","journal-title":"JAMA Internal Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263210","article-title":"Trends in underlying causes of death in solid organ transplant recipients between 2010 and 2020: Using the CLASS method for determining specific causes of death","volume":"17","author":"Soborg","year":"2022","journal-title":"PLoS One"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14208","article-title":"Infection in organ transplantation","volume":"17","author":"Fishman","year":"2017","journal-title":"Am J Transpl"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-019-05597-y","article-title":"Diagnostic\u00a0and therapeutic approach to infectious diseases in solid organ transplant\u00a0recipients","volume":"45","author":"Timsit","year":"2019","journal-title":"Intensive Care Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.08.005","article-title":"An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants","volume":"98","author":"Caillard","year":"2020","journal-title":"Kidney Int"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15941","article-title":"COVID-19 in solid organ transplant recipients: Initial report from the US epicenter","volume":"20","author":"Pereira","year":"2020","journal-title":"Am J Transpl"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16865","article-title":"Sex and organ-specific risk of major adverse renal or cardiac events in solid organ transplant recipients with COVID-19","volume":"22","author":"Vinson","year":"2022","journal-title":"Am J Transpl"},{"key":"B9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12016-022-08921-5","article-title":"Risk and protective factors for COVID-19 morbidity, severity, and mortality","volume":"64","author":"Zhang","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.17117","article-title":"The risk and consequences of breakthrough SARS-CoV-2 infection in solid organ transplant recipients relative to non-immunosuppressed controls","volume":"22","author":"Vinson","year":"2022","journal-title":"Am J Transpl"},{"key":"B11","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3390\/vaccines10050800","article-title":"Vaccination for the prevention of infection among immunocompromised patients: A concise review of recent systematic reviews","volume":"10","author":"See","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix1081","article-title":"A systematic review of safety and immunogenicity of influenza vaccination strategies in solid organ transplant recipients","volume":"66","author":"Chong","year":"2018","journal-title":"Clin Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3390\/jcm8050590","article-title":"Alternative-dose versus standard-dose trivalent influenza vaccines for immunocompromised patients: A meta-analysis of randomised control trials","volume":"8","author":"Lai","year":"2019","journal-title":"J Clin Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1126\/science.abm3425","article-title":"Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial","volume":"375","author":"Gilbert","year":"2022","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0266852","article-title":"Does a humoral correlate of protection exist for SARS-CoV-2? A systematic review","volume":"17","author":"Perry","year":"2022","journal-title":"PLoS One"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01122-w","article-title":"The T cell immune response against SARS-CoV-2","volume":"23","author":"Moss","year":"2022","journal-title":"Nat Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-021-00367-7","article-title":"How \u2018killer\u2019 T cells could boost COVID immunity in face of new variants","volume":"590","author":"Ledford","year":"2021","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"108728","DOI":"10.1016\/j.celrep.2021.108728","article-title":"Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients","volume":"34","author":"Tan","year":"2021","journal-title":"Cell Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00625-9","article-title":"T cell-oriented strategies for controlling the COVID-19 pandemic","volume":"21","author":"Noh","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjmed-2022-000468","article-title":"T cell immune memory after covid-19 and vaccination","volume":"2","author":"Wang","year":"2023","journal-title":"BMJ Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.anai.2022.10.003","article-title":"Enhanced SARS-CoV-2 IgG durability following COVID-19 mRNA booster vaccination and comparison of BNT162b2 with mRNA-1273","volume":"130","author":"Ailsworth","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3390\/pathogens12020244","article-title":"SARS-CoV-2-specific T cell responses in immunocompromised individuals with cancer, HIV or solid organ transplants","volume":"12","author":"Reeg","year":"2023","journal-title":"Pathogens"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1513\/pats.200507-073JS","article-title":"Transplant-related immunosuppression A review of immunosuppression and pulmonary infections","volume":"2","author":"Duncan","year":"2005","journal-title":"Proc Am Thorac Society"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/j.immuni.2021.08.001","article-title":"Rapid induction of antigen-specific CD4(+) T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination","volume":"54","author":"Painter","year":"2021","journal-title":"Immunity"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA Vaccine against SARS-CoV-2 - Preliminary Report","volume":"383","author":"Jackson","year":"2020","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1016\/j.cell.2022.05.022","article-title":"Humoral and cellular immune memory to four COVID-19 vaccines","volume":"185","author":"Zhang","year":"2022","journal-title":"Cell"},{"key":"B28","unstructured":"Interim clinical considerations for use of COVID-19 vaccines currently approved or authorized in the United States 2022"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae140","article-title":"Safety and immunogenicity of the mRNA-1273 Coronavirus disease 2019 vaccine in solid organ transplant recipients","volume":"230","author":"Figueroa","year":"2024","journal-title":"J Infect Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"100354","DOI":"10.1016\/j.xcrm.2021.100354","article-title":"Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells","volume":"2","author":"Cohen","year":"2021","journal-title":"Cell Rep Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jim.2007.03.002","article-title":"Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination","volume":"323","author":"Horton","year":"2007","journal-title":"J Immunol Methods"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3187","article-title":"COMPASS identifies T-cell subsets correlated with clinical outcomes","volume":"33","author":"Lin","year":"2015","journal-title":"Nat Biotechnol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/cas.v111.6","article-title":"CD4(+) T cells support polyfunctionality of cytotoxic CD8(+) T cells with memory potential in immunological control of tumor","volume":"111","author":"Imai","year":"2020","journal-title":"Cancer Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1126\/science.abj9853","article-title":"Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells","volume":"374","author":"Mateus","year":"2021","journal-title":"Science"},{"key":"B35","article-title":"T cells in transplantation: ready and willing to reject","author":"Mason","year":"2022","journal-title":"Nature Milestones: T cells"},{"key":"B36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.29245\/2578-3009\/2019\/4.1178","article-title":"Immunosuppressive drugs in organ transplantation to\u00a0prevent allograft rejection: Mode of action and side effects","volume":"3","author":"Claeys","year":"2019","journal-title":"J Immunol Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.12.029","article-title":"A comprehensive assessment of long-term SARS-CoV-2\u2013specific adaptive immune memory in convalescent COVID-19 Solid Organ Transplant recipients","volume":"101","author":"Fava","year":"2022","journal-title":"Kidney Int"},{"key":"B38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s43856-024-00448-4","article-title":"Humoral and cellular immune responses to COVID-19 mRNA vaccines in immunosuppressed liver transplant recipients","volume":"4","author":"Nogimori","year":"2024","journal-title":"Commun Med (Lond)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5281\/zenodo.2530969","article-title":"Immunomodulatory effects of tacrolimus (FK506) for the treatment of allergic diseases","volume":"1","author":"Kandikattu","year":"2018","journal-title":"Int J Cell Biol Physiol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.01.007","article-title":"Adaptive immunity to SARS-CoV-2 and COVID-19","volume":"184","author":"Sette","year":"2021","journal-title":"Cell"},{"key":"B41","doi-asserted-by":"publisher","first-page":"101495","DOI":"10.1016\/j.trim.2021.101495","article-title":"T helper type (Th1\/Th2) responses to SARS-CoV-2 and influenza A (H1N1) virus: From cytokines produced to immune responses","volume":"70","author":"Aleebrahim-Dehkordi","year":"2022","journal-title":"Transpl Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128714","article-title":"Pathogen-specific T cell polyfunctionality is a correlate of T cell efficacy and immune protection","volume":"10","author":"Boyd","year":"2015","journal-title":"PloS One"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.7489","article-title":"Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid\u00a0organ\u00a0transplant recipients","volume":"325","author":"Boyarsky","year":"2021","journal-title":"JAMA"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.12339","article-title":"Antibody response after a third dose of the mRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients with minimal serologic response to 2 doses","volume":"326","author":"Benotmane","year":"2021","journal-title":"JAMA"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2021.7372","article-title":"Comparison of SARS-CoV-2 antibody response 4 weeks after homologous vs heterologous third vaccine dose in kidney transplant recipients: A randomized clinical trial","volume":"182","author":"Reindl-Schwaighofer","year":"2022","journal-title":"JAMA Intern Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2021.07.026","article-title":"SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients","volume":"40","author":"Hallett","year":"2021","journal-title":"J Heart Lung Transpl"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1505871\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T01:09:57Z","timestamp":1743728997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1505871\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":46,"alternative-id":["10.3389\/fimmu.2025.1505871"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1505871","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"article-number":"1505871"}}